Port Erin Biopharma up 14.76% today – Did you miss out on the free share tip?
By
Tom Winnifrith
PUBLISHED:
02 Jan 2013 @ 19:11
|
Comments (0)
|
More info about Tom Winnifrith
Shares in AIM listed Port Erin Biopharma (LSE:PEBI) jumped by almost 15% today to 6p. The whole movement occurred after the stock was recommended by the new Onefreesharetip.com service as its inaugural share tip. For what it is worth the target price is 9p.
If you missed out on this share tip from myself do not miss out on tomorrow’s recommendation – the tip of the year from ADVFN boss and globally syndicated columnist Clem Chambers. It will be sent to the thousands of investors who have already registered with Onefreesharetip.com at 11 AM.
And on Friday ex t1ps.com Senior writer Steve Moore will be publishing his tip of the year only on Onefreesharetip.com – thereafter the service will send out one share tip each working day from a panel of 20 leading share tipsters, bloggers and analysts. Why miss out? It is all free to get on board and make sure that you do not miss out tomorrow register here
CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).
This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Plc. ADVFN Plc does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.
Hot Features
Premium
Register for real-time alerts, custom portfolio, and market movers
